Josef Brüggen
Utrecht University(NL)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Monoclonal and Polyclonal Antibodies Research, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, HER2/EGFR in Cancer Research
Most-Cited Works
- → Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl(2005)1,480 cited
- → Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis(1987)696 cited
- → New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis(2000)213 cited
- → Phenotypic dynamics of tumor progression in human malignant melanoma(1985)169 cited
- → Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis(2003)134 cited
- → Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase Inhibitors(2002)103 cited
- → Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens(1980)90 cited
- → Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinases(2004)65 cited
- Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines.(1986)